MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat myeloma: drug trio shows promise in early trial
Disease control CompletedThis early-phase study tested a combination of three drugs (ibrutinib, lenalidomide, and dexamethasone) in 14 adults with multiple myeloma that had returned or stopped responding to prior treatments. The main goal was to find safe doses and identify side effects. While the approa…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Real-World study tracks myeloma Patients' adherence to drug regimens
Knowledge-focused CompletedThis study looked at how closely adults with multiple myeloma (a type of blood cancer) follow their prescribed treatment with carfilzomib combined with other drugs. It involved 359 patients who had already tried at least one prior therapy. The goal was to understand real-world ad…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC